Browsing by Keyword : Bevacizumab
Showing results 1 to 14 of 14
Pub Year | | Title | AJOU Author(s) |
2023 | | Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report | 권지은, 박영준 |
2024 | | Bevacizumab Alone Versus Bevacizumab Plus Irinotecan in Patients With Recurrent Glioblastoma: A Nationwide Population-Based Study | 김세혁, 노태훈 |
2024 | | Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines | 손주혁, 장석준 |
2014 | | Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma. | 허훈 |
2020 | | Effect of a Single Intravitreal Bevacizumab Injection on Proteinuria in Patients With Diabetes | 김영호, 변혜은, 이기황, 정유리 |
2022 | | Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001) | 공태욱, 손주혁, 장석준 |
2016 | | Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy | 양홍석, 이기황, 정유리 |
2019 | | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | 장석준 |
2022 | | Real-world treatment intensities and pathways of macular edema following retinal vein occlusion in Korea from Common Data Model in ophthalmology | 박래웅, 송지훈, 이기황, 정유리 |
2023 | | Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen | 안미선 |
2018 | | Subfoveal Choroidal Thickness and Vascular Diameter in Active and Resolved Central Serous Chorioretinopathy | 이기황, 정유리 |
2024 | | Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study | 강석윤 |
2019 | | Twelve-Month Efficacy of Intravitreal Bevacizumab Injection for Chronic, Atypical, or Recurrent Central Serous Chorioretinopathy | 송지훈, 정유리 |
2016 | | 만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과 | 김종완, 안재홍 |
1